sexta-feira, 16 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 5, 2026

Tech stocks today: Nvidia stops H200 chip production, Anthropic restarts talks with Pentagon

View original at finance.yahoo.com
Tech stocks today: Nvidia stops H200 chip production, Anthropic restarts talks with Pentagon Nvidia (NVDA) has reportedly halted production of China-bound H200 chips, the Financial Times reported, as regulatory efforts in Washington and Beijing have restricted imports to the Chinese market…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tesla is the current leader in consumer autonomy and will quickly become a leader in robotaxi services due to ability to scale more profitably than competitors

    80% confidence
  • OpenAI's agreement with DOD has more guardrails than any previous agreement for classified AI deployments, including Anthropic's

    80% confidence
  • Nvidia will invest $30 billion in OpenAI and this might be the last opportunity to invest before OpenAI goes public

    80% confidence
  • AI revenue growth is accelerating

    80% confidence
  • CPU and GPU growth is not a zero-sum game because there are more and more workloads

    80% confidence
  • With Coherent, Nvidia is pioneering next-generation silicon photonics to enable AI infrastructure at unprecedented scale, speed and energy efficiency

    80% confidence
  • Computing has fundamentally changed and in the age of AI, software runs on intelligence with tokens generated in real time by AI factories

    80% confidence
  • OpenAI is working with DOD to make additions to agreement to make principles very clear

    80% confidence
  • MacBook Neo represents a shift in the history of the Mac as Apple has always positioned MacBook as a premium product with entry prices near or above $999

    80% confidence
  • Autonomous vehicles and robotaxis will be the most significant change agent in the Auto 2.0 landscape

    80% confidence
  • Broadcom achieved record Q1 revenue driven by continued strength in AI semiconductor solutions

    80% confidence
  • Nvidia has not generated any revenue from H200 chips to China-based customers yet and does not know whether any imports will be allowed

    80% confidence
  • OpenAI was genuinely trying to de-escalate and avoid worse outcome but it looked opportunistic and sloppy

    80% confidence
  • Nvidia's $10 billion investment in Anthropic will probably be the last before anticipated IPO

    80% confidence
  • OpenAI retains full discretion over safety stack, deploys via cloud, has cleared personnel in the loop, and has strong contractual protections

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,378 documentos-fonte arquivados
Consulte estes dados → isubstrate.com